What are the possible causes and treatments for a lump on the back of the skin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of a Skin Lump on the Back

For any unexplained lump on the back, obtain an urgent ultrasound within 2 weeks to assess for soft tissue sarcoma if the lump is increasing in size, and refer to a specialist sarcoma multidisciplinary team if ultrasound findings are suggestive or uncertain with persistent clinical concern. 1

Initial Clinical Assessment

When evaluating a back lump, immediately assess for high-risk features that determine urgency:

Red Flag Features Requiring Urgent Evaluation 1

  • Size greater than 3 cm - significantly increases malignancy risk 2
  • Deep location - fixed to or located deep to fascia 2
  • Rapid or progressive growth 2
  • Firm consistency 2
  • Skin ulceration or bleeding 3
  • Pain 3
  • Onset in neonatal period (for pediatric patients) 2

Specific Skin Changes Requiring Imaging 1

  • Hairy patch - may indicate spinal dysraphism 1
  • Skin discoloration or capillary malformation - associated with underlying spinal cord malformations 1
  • Dermal sinus tract or draining sinus - requires MRI to evaluate for intraspinal lesions 1
  • Subcutaneous mass with overlying skin changes - consider spinal cord malformation 1

Diagnostic Pathway

For Adults with Soft Tissue Lumps 1

Step 1: Urgent Ultrasound (within 2 weeks)

  • Ultrasound effectively discriminates benign from malignant soft tissue masses 1
  • Most soft tissue lumps are benign lipomas, which can be safely reassured after ultrasound 1
  • Ultrasound is highly user-dependent; if diagnostic uncertainty exists, proceed to MRI 1

Step 2: If Ultrasound Suggests Malignancy or Remains Uncertain

  • Refer via suspected cancer pathway (appointment within 2 weeks) 1
  • MRI of the affected region provides the most accurate diagnostic information for soft tissue tumors of the trunk 1
  • Do not perform excisional biopsy before specialist evaluation - obtain core/punch biopsy to guide surgical planning 1

For Pediatric Patients with Associated Skin Findings 1

Neonates and Infants <4 months:

  • Ultrasound of the spine is the initial modality for evaluating spinal dysraphism when skin abnormalities are present 1

Older Children:

  • MRI spine of the area of interest without IV contrast is appropriate initial imaging 1
  • MRI with and without IV contrast if suspected neoplasm or infected dermal sinus tract 1

Common Benign Diagnoses

Lipomas 1, 4

  • Most common soft tissue mass seen in primary care 1
  • Typically superficial, soft, mobile, and slow-growing 4
  • Atypical lipomatous tumors (well-differentiated liposarcomas) are less common but tend to be larger, deep-seated, and require specialist evaluation 1
  • MRI can differentiate lipomas from atypical lipomatous tumors in up to 69% of cases based on nodularity, septations, and stranding 1

Epidermoid Cysts 4

  • Common benign tumors typically treated with excision 4
  • May become inflamed or infected

Dermatofibromas 4

  • Firm dermal nodules, often treated with excision if symptomatic 4

Malignant Considerations

Soft Tissue Sarcomas 1

  • Approximately 1% of superficial lumps in children are malignant 2
  • Five risk factors identify 80% of malignant lesions: neonatal onset, rapid/progressive growth, ulceration, deep fixation, and firm mass >3 cm 2
  • In absence of all five risk factors, 99.7% accuracy for benign diagnosis 2

Cutaneous Malignancies 3, 5

  • Cutaneous horns on sun-exposed areas in elderly males with bleeding, pain, or rapid growth require complete excisional biopsy with 2-4 mm margins 3
  • Melanoma risk factors include UV exposure, fair skin, dysplastic nevi, and family history 5
  • Any suspicious pigmented lesion requires biopsy with deep scoop shave, saucerization, or full-thickness excision 5

Critical Management Principles

Biopsy Technique for Suspected Malignancy 1, 3:

  • Obtain core/punch biopsy before definitive surgery to guide surgical planning 1
  • Avoid shave biopsies or partial removal of keratotic projections - these prevent accurate diagnosis 3
  • Complete excisional biopsy with margins is required for cutaneous horns and suspicious pigmented lesions 3, 5

When to Observe vs. Excise 2, 4:

  • Approximately 6% of benign superficial lumps spontaneously regress 2
  • In absence of risk factors, observation is reasonable with patient reassurance 2
  • Elective excision indicated for cosmetic concerns, prevention of late infection, or diagnostic certainty 2, 4

Common Pitfalls to Avoid

  • Do not perform excisional biopsy of large or deep masses before imaging - this compromises subsequent surgical planning 1
  • Do not reassure patients with lipomatous masses >5 cm or deep-seated lesions without specialist evaluation - these may be atypical lipomatous tumors requiring different management 1
  • Do not ignore skin markers in pediatric patients - hairy patches, discoloration, or dimples may indicate serious underlying spinal cord malformations requiring MRI 1
  • Do not delay ultrasound for growing lumps - the 2-week window for urgent assessment is critical for early sarcoma detection 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cutaneous Horn Evaluation and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Common benign skin tumors.

American family physician, 2003

Research

Melanoma: Diagnosis and Treatment.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.